ADAMtx: Development of Alzheimer’s immunotherapy by harnessing the natural reparative properties of microglia

Project Information

ADAMtx

Grant agreement ID: 862571

DOI 10.3030/862571

Project closed

EC signature date 25 September 2019

Start date 1 October 2019

End date 31 March 2021

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost € 0,00

EU contribution € 150 000,00

Coordinated by

WEIZMANN INSTITUTE OF SCIENCE
Israel